$2.75
4.18%
Nasdaq, Sep 12, 10:17 pm CET
ISIN
US0144421072
Symbol
ALEC

Alector, Inc. Stock price

$2.75
+0.75 37.50% 1M
+1.24 82.12% 6M
+0.86 45.50% YTD
-2.86 50.98% 1Y
-7.42 72.96% 3Y
-10.95 79.93% 5Y
-13.88 83.46% 10Y
-13.88 83.46% 20Y
Nasdaq, Closing price Fri, Sep 12 2025
-0.12 4.18%
ISIN
US0144421072
Symbol
ALEC
Industry

Key metrics

Basic
Market capitalization
$278.3m
Enterprise Value
$-19.4m
Net debt
positive
Cash
$307.3m
Shares outstanding
101.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.4 | 17.8
EV/Sales
negative | negative
EV/FCF
0.1
P/B
3.9
Financial Health
Equity Ratio
27.1%
Return on Equity
-93.9%
ROCE
-49.4%
ROIC
1,939.1%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$81.1m | $15.6m
EBITDA
$-123.5m | $-223.6m
EBIT
$-134.5m | $-174.2m
Net Income
$-115.3m | $-158.9m
Free Cash Flow
$-216.0m
Growth (TTM | estimate)
Revenue
46.8% | -84.4%
EBITDA
32.0% | -64.2%
EBIT
28.2% | -20.2%
Net Income
28.3% | -33.4%
Free Cash Flow
0.8%
Margin (TTM | estimate)
Gross
-
EBITDA
-152.2% | -1,428.9%
EBIT
-165.8%
Net
-142.1% | -1,015.3%
Free Cash Flow
-266.3%
More
EPS
$-1.2
FCF per Share
$-2.1
Short interest
6.8%
Employees
238
Rev per Employee
$420.0k
Show more

Is Alector, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Alector, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Alector, Inc. forecast:

11x Buy
73%
2x Hold
13%
2x Sell
13%

Analyst Opinions

15 Analysts have issued a Alector, Inc. forecast:

Buy
73%
Hold
13%
Sell
13%

Financial data from Alector, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
81 81
47% 47%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 58 58
1% 1%
71%
- Research and Development Expense 156 156
16% 16%
192%
-123 -123
32% 32%
-152%
- Depreciation and Amortization 11 11
92% 92%
14%
EBIT (Operating Income) EBIT -135 -135
28% 28%
-166%
Net Profit -115 -115
28% 28%
-142%

In millions USD.

Don't miss a Thing! We will send you all news about Alector, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alector, Inc. Stock News

Neutral
Seeking Alpha
6 days ago
Alector, Inc. (NASDAQ:ALEC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:00 AM EDT Company Participants Arnon Rosenthal - Co-Founder, CEO & Director Conference Call Participants Sean Laaman - Morgan Stanley, Research Division Presentation Sean Laaman Head of Healthcare Research & Equity Analyst Good morning, everyone, and welcome to Morgan Stanley Global Healthc...
Neutral
GlobeNewsWire
17 days ago
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in the following upcoming investor conferences: Cantor Global Healthcare Conference 2025 (New York, New York) Thurs...
Neutral
Seeking Alpha
about one month ago
Alector, Inc. (NASDAQ:ALEC ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Arnon Rosenthal - Co-Founder, CEO & Director Giacomo Salvadore - Chief Medical Officer Katie Hogan - Senior Director of Corporate Communication & Investor Relations Neil Berkley - Interim CFO & Chief Business Officer Saraswati Kenkare-Mitra - President and Head of Research & Development ...
More Alector, Inc. News

Company Profile

Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Head office United States
CEO Arnon Rosenthal
Employees 238
Founded 2013
Website alector.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today